Abstract:Aim: We aim to explore the repair effect of combined cell therapy using activated Schwann cells (ASCs) and bone mesenchymal stem cells (BMSCs) in traumatic spinal cord injury (SCI) in rats. Materials & methods: ASCs and BMSCs were used for combined transplantation to treat acute SCI in rats, both of which can be obtained from SCI patients. ASCs were obtained by prior ligation of saphenous nerve and BMSCs by flush of the marrow cavity with Dulbecco's modified Eagle's medium solution. Our experiment in vitro confirmed that ASCs promoted BMSCs to differentiate into mature neural cells. It also indicates that BMSCs hold the potential to repair CNS injury. ASCs and BMSCs were co-transplanted into the injured epicenter of spinal cord made by the New York University (NYU) impactor machine using a 10 g x 50 mm drop weight. Complete ASCs, BMSCs and Dulbecco's modified Eagle's medium were also transplanted in rats with SCI as a control. Recovery of rat's hindlimb function was serially evaluated by Basso, Beattie, Bresnahan locomotor rating scale and footprint ana-lysis. Changes of neurological potential were recorded by nerve electrophysiologic test. Improvement in the microenvironment of the injured spinal cord was evaluated by hematoxylin and eosin staining, glial fibrillary acidic protein staining, biotinylated dextran amine anterograde tracing and electron microscopy. Results: Using biotinylated dextran amine anterograde tracing, we demonstrated that there were more regenerative axons of corticospinal tract surrounding and passing through the injured cavity to the caudal cord in the ASC-BMSC co-graft group than those in the other three groups, and we also confirmed this further by quantitative ana-lysis. Immunostaining for glial fibrillary acidic protein showed the smallest population of astrocytes in the injury epicenter in the ASC-BMSC group compared with the other three groups. Relatively complete myelin sheaths and organelles were found in the ASC-BMSC group compared with the other three groups under electron microscopy. Conclusion: Effective co-transplantation of ASCs and BMSCs promotes functional recovery in rats' hindlimbs and reduces the formation of glial scar, and remyelinates the injured axons as compared with the other three groups. This conclusion was also supported by the observation of immunohistochemistry staining and electron microscopy, suggesting the possible clinical application for the treatment of spinal injury.

Combining Bone Marrow Stromal Cells with Green Tea Polyphenols Attenuates the Blood-Spinal Cord Barrier Permeability in Rats with Compression Spinal Cord Injury

Bone Marrow Mesenchymal Stem Cells (bmscs) Improved Functional Recovery of Spinal Cord Injury Partly by Promoting Axonal Regeneration

Thrombospondin-1 Modified Bone Marrow Mesenchymal Stem Cells (bmscs) Promote Neurite Outgrowth and Functional Recovery in Rats with Spinal Cord Injury.

Bone marrow stromal cells inhibit caspase-12 expression in rats with spinal cord injury.

Bone Marrow Mesenchymal Stem Cells Combined with Minocycline Improve Spinal Cord Injury in A Rat Model

Bone Marrow Mesenchymal Stem Cells Decrease CHOP Expression and Neuronal Apoptosis after Spinal Cord Injury.

Calpain Inhibitor Attenuates ER Stress-Induced Apoptosis in Injured Spinal Cord after Bone Mesenchymal Stem Cells Transplantation

Mitochondrial Transfer from Bone Marrow Mesenchymal Stem Cells to Motor Neurons in Spinal Cord Injury Rats via Gap Junction.

Bone Marrow Mesenchymal Stem Cells Transplantation Combined with Exercise Training Synergistically Promoted Functional Recovery After Spinal Cord Injury.

Enhanced effect of combining bone marrow mesenchymal stem cells (BMMSCs) and pulsed electromagnetic fields (PEMF) to promote recovery after spinal cord injury in mice

Bone marrow mesenchymal stem cells improve spinal function of spinal cord injury in rats via TGF-β/Smads signaling pathway

Neuroprotective Effect of Bone Marrow Stromal Cell Combination with Atorvastatin in Rat Model of Spinal Cord Injury.

Combination of Activated Schwann Cells with Bone Mesenchymal Stem Cells: the Best Cell Strategy for Repair after Spinal Cord Injury in Rats

Effect of TNF-α Inhibition on Bone Marrow-Derived Mesenchymal Stem Cells in Neurological Function Recovery after Spinal Cord Injury Via the Wnt Signaling Pathway in a Rat Model

Transplantation Of Bone Marrow Mesenchymal Stem Cells Inhibits Apoptosis In Injured Rat Spinal Cord

Human Brain–Derived Neurotrophic Factor Gene-Modified Bone Marrow Mesenchymal Stem Cells Combined With Erythropoietin Can Improve Acute Spinal Cord Injury

Research on the effect and mechanism of the CXCR-4-overexpressing BMSCs combined with SDF-1 alpha for the cure of acute SCI in rats

Sodium Tanshinone IIA Silate Exerts Microcirculation Protective Effects Against Spinal Cord Injury in Vitro and in Vivo.

Therapeutic Mechanisms for Blood–Spinal Cord Barrier Repair Following Spinal Cord Injury

Tetramethylpyrazine-loaded electroconductive hydrogels promote tissue repair after spinal cord injury by protecting the blood–spinal cord barrier and neurons

Combination use of human menstrual blood stem cell- derived exosomes and hyperbaric oxygen therapy, synergistically promote recovery after spinal cord injury in rats